Administration of CIGB-247 in solid malignant tumors. Phase I study on scaling up dosages

Trial Profile

Administration of CIGB-247 in solid malignant tumors. Phase I study on scaling up dosages

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs CIGB 247 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Acronyms CENTAURO
  • Most Recent Events

    • 14 Jan 2015 New trial record
    • 19 Nov 2014 Results published in the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top